Abstract Submissions are Open
Deadline: October 26, 2021
Accepted Abstracts will be published in Metabolism
Accepted Abstracts will have a poster presentation at the meeting
Top Abstracts will be selected for oral presentations at the meeting
In some cases, the committee may consider Late-Breaking Abstracts for oral presentation
Top 4 Abstracts will receive awards and cash prizes
*Please note, if an author wishes to make changes or withdraw their abstract, they must contact the WCIRDC team no later than November 13, 2021. WCIRDC cannot guarantee that any change or withdrawal requests submitted after this date will be accommodated. All requests should be submitted via e-mail to firstname.lastname@example.org
View Sample Abstract Submission
Abstract Submission & Topics
Clinical aspects of insulin resistance in childhood, adolescence, and/or adulthood pertaining to:
Diabetes, obesity, dyslipidemia, hypertension, cardiovascular disease, malignancy, liver disease, renal disease, gonadal dysfunction, sleep disorders such as obstructive sleep apnea.
Mechanisms of insulin resistance, inflammation, endothelial and vascular dysfunction, metabolic dysfunction of centers such as the beta cell, adipocyte, gut, and brain.
Abstracts should address either clinical or basic science aspects of insulin resistance, in fields such as diabetes, obesity, and cardiovascular disease. Investigations of overall pathophysiology and/or effects on key metabolic centers such as the beta cell, adipocyte, gut, and brain would be of interest, as would be studies of inflammation and of endothelial or other vascular dysfunction. Clinical topics may include any aspect of insulin resistance in childhood, adolescence, and/or adulthood in relation to the causation and/or natural history of obesity, diabetes, hypertension, dyslipidemia, cardiovascular disease, renal disease, gonadal dysfunction (including both PCOS and male hypogonadism), gestational diabetes, other endocrine abnormality, liver disease (NAFLD), malignancy, and sleep disorders such as obstructive sleep apnea.
The interests of the Congress include multi-hormonal aspects of obesity, incretins, and other gut hormonal contributions to energy balance, and circadian rhythm as it relates to these metabolic mechanisms. Basic science studies should include those with a specific relationship to insulin action and its regulation at the cellular, organ, or whole-body level.
To demonstrate their conformity to this guideline, authors are encouraged to include a brief clarification of the relationship of their topic to insulin resistance and/or to the above metabolic processes.
Abstract Poster Presentations
Abstracts may be submitted for a poster presentation. If selected for poster presentation, the author or presenter is required to register for the free congress and to be present during the poster sessions. The presenter in attendance must be one of the authors listed on the abstract.
Abstract Oral Presentations
4 of the highest-ranking abstracts will be selected for the Abstract Oral Presentation Session - please view the agenda for dates and times of the oral presentation session. In some cases, the committee may consider Late-Breaking Abstracts for oral presentation. The authors of the winning abstracts will present their research findings in a 10-minute presentation, followed by a 5 minute period of Q&A. If selected, an author is required to register to the meeting and to be prepared with a PowerPoint presentation. Oral presenters who have an interest or involvement in selling a technology, program, product, and/or service to healthcare professionals must submit an official disclosure document in order to be considered for and to present their work at the abstract oral session.
Top Abstract Awards
Awards will be given to the highest-ranking abstracts. The award levels are: Gold, Silver, Bronze, and honorable mentions and are chosen from the Abstract Oral Winners.
Scientific materials presented at the 19th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (2021) must not have been published or presented prior to December 2, 2021, other than in abstract form.
All abstracts must be submitted electronically on a Microsoft Word document of no more than 250 words. Please do not submit any graphs, tables, figures, or references (No PDF documents will be accepted, or any submissions by fax or mail). For sample formatting, please click here.
All materials must arrive on or before the abstract deadline noted above.
Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.
Authorship on multiple abstracts is permitted.
All submitted materials will be graded by the scientific planning committee, The International Committee for Insulin Resistance.
Abstracts will be published in Metabolism following the 19th WCIRDC meeting.